Vimarsana
Biggest News Aggregation in the World

Page 6 - Clinical Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Diagnostics Today - Breaking & Trending Today

Study of first affordable test for beta thalassemia - Vimarsana News

Study of first affordable test for beta thalassemia

A clinical study validates the beta thalassemia diagnostic capability of the Gazelle Hb Variant Test

Exploring Spatial Interactomics for Deeper Insights into the Tumor Microenvironment on SelectScience - Vimarsana News

Exploring Spatial Interactomics for Deeper Insights into the Tumor Microenvironment on SelectScience

Watch the latest scientific webinars on SelectScience.

Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Michael Crowley Sells 3,000 Shares - Vimarsana News

Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Michael Crowley Sells 3,000 Shares

Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) EVP Michael Crowley sold 3,000 shares of Bio-Rad Laboratories stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $336.00, for a total transaction of $1,008,000.00. Following the completion of the transaction, the executive vice president now directly owns 6,942 […]

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production - Vimarsana News

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digitalâ„¢ PCR During Cell and Gene Therapy Production.

Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Increased by Federated Hermes Inc. - Vimarsana News

Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Increased by Federated Hermes Inc.

Federated Hermes Inc. boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 34.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,728 shares of the medical research company’s stock after purchasing an additional 15,871 shares during the period. Federated Hermes […]